"Today's actions demonstrate our commitment to public health in proactively fighting against the COVID-19 pandemic," the FDA commissioner said.
An FDA expert panel vote to approve a Johnson & Johnson booster shot two months after the first dose. Follow Newsweek's liveblog for all the latest.
If it does recommend a booster for J&J, the agency will also need to decide whether recipients should get the shot two months or six months after initial vaccination.
"On the basis of literally hundreds and hundreds and hundreds of millions of vaccinations that we've had, the safety of these vaccines has been clearly established."
Jessica Berg Wilson is the fourth person to die from a complication of the J&J vaccine out of over 8 million recipients of the shot.
Health Minister Janez Poklukar said the vaccine's "benefits continue to outweigh the risks," as Slovenia investigates the death of a vaccinated woman.
62 percent of all respondents said booster shots show "scientists are continuing to find ways to make vaccines more effective."
The Indian prime minister is due to meet Joe Biden on September 24 in Washington D.C.
The company's chief scientific officer said a second shot increases protection against the virus and extends the duration of protection.
The Republican governor said seniors who live in congregate care settings are now authorized for COVID-19 booster shots.
The Pfizer vaccine can now be marketed and will be referred to as Comirnaty.
The jail administration's delay came because it reportedly wanted to provide only the Johnson & Johnson vaccine to the prisoners.
The threat of the Delta variant combined with people gathering indoors during winter was cited as reasons to get a third shot for increased immunity.
The problems in production have cause Johnson & Johnson to import millions of vaccines from its factory in the Netherlands and miss supply commitments.
A doctor in Alabama wrote on social media about the emotional experience of telling unvaccinated people it was too late to be inoculated.
More than 500,000 deaths in the U.S. have been connected to opioid prescription drugs and illegal opioids since 2000.
Guillain-Barre syndrome is a rare autoimmune disorder where one's own immune system attacks the nerves, causing muscle weakness and sometimes paralysis.
South Africa will discard about two million Johnson & Johnson vaccines after the U.S. FDA deemed them unsuitable for use. The administration believes the doses may have been manufactured with contaminated ingredients from a Baltimore facility.
FDA allowed two more batches of Johnson & Johnson's COVID-19 vaccine to dispatch but said because of the possibility of contamination, other batches should not be released. Additional batches are still under review.
Johnson & Johnson received approval from the FDA to extend the expiration date of vaccine doses by six weeks as the number of vaccines administered daily falls.
The CDC director for Africa said he is "optimistic the U.S. will lift its hold on 1.1 million J&J vaccines currently detained in South Africa. The doses were held following contamination concerns at a U.S. facility.
After contamination concerns at a U.S. factory, more than 1 million Johnson & Johnson vaccines are sitting unused in a South African pharmaceutical facility.
"Lisa developed severe headaches a week after receiving her AstraZeneca vaccine and fell seriously ill a few days later," Shaw's family said.
A Minnesota man posted a video of himself to social media that appeared to show him stealing a vial of the COVID-19 vaccine in order to "test it at a lab."
The COVID-19 shot was removed from the country's vaccination program as investigations continue into its risks
Many of the 64 people who were affected reported either fainting or experiencing dizziness, while others became nauseous or vomited, and a few had racing hearts, chest pain or other symptoms.
There were 15 reported blood clots and one death from the single-dose vaccine, which made the federal government pause the vaccine to begin with.
Among the 8 million who received doses of the vaccine so far,15 cases of the disorder have been identified, resulting in at least one death.
The FDA released a report on Wednesday detailing troubling conditions at Baltimore's Emergent plant.
"Healthcare professionals and people who will receive the vaccine should be aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within three weeks of vaccination," the European Medicines Agency said.